Julia Lackenby
The University of Queensland(AU)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Bacterial Infections and Vaccines, Parasitic infections in humans and animals, Animal Virus Infections Studies
Most-Cited Works
- → Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial(2021)117 cited
- → Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2(2021)61 cited
- → Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigens(2012)45 cited
- → Effect of water temperature on reproductive development of Benedenia seriolae (Monogenea: Capsalidae) from Seriola lalandi in Australia(2007)45 cited
- → Rapid Response Subunit Vaccine Design in the Absence of Structural Information(2020)19 cited
- → Molecular clamp stabilised Spike protein for protection against SARS-CoV-2(2020)15 cited
- → Variation in the cellular localization of host‐protective oncospheral antigens inTaenia saginataandTaenia solium(2010)10 cited
- → HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors(2024)7 cited
- → Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18–55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial(2023)5 cited
- → First Report of a Phase 1 Randomised Trial of Molecular Clamp-Stabilised Spike Protein-Based and MF59-Adjuvanted Vaccine for SARS-CoV-2(2021)2 cited